Terms: = Uterine cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566
115 results:
1. [Application of optical coherence tomography in the evaluation of cervical lesions: a multicenter study].
Zhang W; Cao YS; Wei MC; Xu J; Bao Z; Yan JX; Chen C; Li JY; Ban ZY; Wang BJ; Zhao X; Zhao C; Zeng XX
Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):299-306. PubMed ID: 38644276
[No Abstract] [Full Text] [Related]
2. Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations.
Khushman MM; Toboni MD; Xiu J; Manne U; Farrell A; Lou E; Shields AF; Philip PA; Salem ME; Abraham J; Spetzler D; Marshall J; Jayachandran P; Hall MJ; Lenz HJ; Sahin IH; Seeber A; Powell MA
Clin Cancer Res; 2024 May; 30(9):1906-1915. PubMed ID: 38350001
[TBL] [Abstract] [Full Text] [Related]
3. A novel nomogram and risk stratification for early metastasis in cervical cancer after radical radiotherapy.
Liu L; Lin J; Deng S; Yu H; Xie N; Sun Y
Cancer Med; 2023 Dec; 12(24):21798-21806. PubMed ID: 37994611
[TBL] [Abstract] [Full Text] [Related]
4. [Hsa_circ_0000392 affects the radiation sensitivity of cervical cancer by targeting the miR-145-5p/CRKL/MAPK pathway].
Tian J; Wang N; Wang C; Wu DP; Wang CH; Ding XJ; Wang YK
Zhonghua Zhong Liu Za Zhi; 2023 Oct; 45(10):879-891. PubMed ID: 37875424
[No Abstract] [Full Text] [Related]
5. BUB1, bub1b, CCNA2, and CDCA8, along with miR-524-5p, as clinically relevant biomarkers for the diagnosis and treatment of endometrial carcinoma.
Hao Q; Wu H; Liu E; Wang L
BMC Cancer; 2023 Oct; 23(1):995. PubMed ID: 37853361
[TBL] [Abstract] [Full Text] [Related]
6. Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study.
Dhokotera TG; Muchengeti M; Davidović M; Rohner E; Olago V; Egger M; Bohlius J
Int J Cancer; 2024 Jan; 154(2):284-296. PubMed ID: 37682630
[TBL] [Abstract] [Full Text] [Related]
7. Which factors predict parametrial involvement in stage IB cervical cancer? A Chinese multicentre study.
Liang C; Jiang H; Sun L; Kang S; Cui Z; Wang L; Zhao W; Bin X; Lang J; Liu P; Chen C
Eur J Surg Oncol; 2023 Sep; 49(9):106936. PubMed ID: 37244844
[TBL] [Abstract] [Full Text] [Related]
8. Identification of key molecular players and associated pathways in cervical squamous cell carcinoma progression through network analysis.
Thippana M; Dwivedi A; Das A; Palanisamy M; Vindal V
Proteins; 2023 Aug; 91(8):1173-1187. PubMed ID: 37119038
[TBL] [Abstract] [Full Text] [Related]
9. The influence of overweight and obesity on participation in cervical cancer screening: A systematic review and meta-analysis.
Sand FL; Urbute A; Ring LL; Kjaer AK; Belmonte F; Kjaer SK
Prev Med; 2023 Jul; 172():107519. PubMed ID: 37080502
[TBL] [Abstract] [Full Text] [Related]
10. Adjuvant Human Papillomavirus Vaccination After Excisional Procedure for Cervical Intraepithelial Neoplasia: A Cost-Effectiveness Analysis.
Chaiken SR; Bruegl AS; Caughey AB; Emerson J; Munro EG
Obstet Gynecol; 2023 Apr; 141(4):756-763. PubMed ID: 36897145
[TBL] [Abstract] [Full Text] [Related]
11. Human Papillomavirus Intermittence and Risk Factors Associated With First Detections and Redetections in the Ludwig-McGill Cohort Study of Adult Women.
Malagón T; Trottier H; El-Zein M; Villa LL; Franco EL;
J Infect Dis; 2023 Aug; 228(4):402-411. PubMed ID: 36790831
[TBL] [Abstract] [Full Text] [Related]
12. More than cervical cancer: Understanding racial/ethnic disparities in oropharyngeal cancer outcomes among males by HPV status.
Villalona S; Ferrante J; Villalona S; Stroup A
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696662
[TBL] [Abstract] [Full Text] [Related]
13. Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making.
Shi L; Liu Y; Li J; Kou J; Ouyang Y; Chen F; Huang X; Huo L; Huang L; Cao X
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5999-6007. PubMed ID: 36624190
[TBL] [Abstract] [Full Text] [Related]
14. Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank.
Ung CY; Warwick A; Onoufriadis A; Barker JN; Parsons M; McGrath JA; Shaw TJ; Dand N
JAMA Dermatol; 2023 Feb; 159(2):172-181. PubMed ID: 36598763
[TBL] [Abstract] [Full Text] [Related]
15. RESOLVE-DWI-based deep learning nomogram for prediction of normal-sized lymph node metastasis in cervical cancer: a preliminary study.
Qian W; Li Z; Chen W; Yin H; Zhang J; Xu J; Hu C
BMC Med Imaging; 2022 Dec; 22(1):221. PubMed ID: 36528577
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of co-testing with cytology and human papillomavirus testing in cervical screening.
Nordqvist Kleppe S; Andersson H; Elfström KM; Dillner J
Prev Med; 2023 Jan; 166():107364. PubMed ID: 36435231
[TBL] [Abstract] [Full Text] [Related]
17. ASPM, CDC20, DLGAP5, bub1b, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma.
Zhang Q; Wang Y; Xue F
Genet Res (Camb); 2022; 2022():3217248. PubMed ID: 36186000
[TBL] [Abstract] [Full Text] [Related]
18. Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics.
Nguyen TB; Do DN; Nguyen-Thi ML; Hoang-The H; Tran TT; Nguyen-Thanh T
Comput Biol Med; 2022 Oct; 149():105996. PubMed ID: 36049413
[TBL] [Abstract] [Full Text] [Related]
19. Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven cancers.
Ghosh S; Mazumdar T; Xu W; Powell RT; Stephan C; Shen L; Shah PA; Pickering CR; Myers JN; Wang J; Frederick MJ; Johnson FM
Clin Cancer Res; 2022 Oct; 28(20):4479-4493. PubMed ID: 35972731
[TBL] [Abstract] [Full Text] [Related]
20. Magnetic resonance spectroscopy associations with clinicopathologic features of estrogen-dependent endometrial cancer.
Zhang J; Liu Q; Li J; Liu Z; Wang X; Li N; Huang Z; Xu H
BMC Med Imaging; 2022 Jul; 22(1):127. PubMed ID: 35850646
[TBL] [Abstract] [Full Text] [Related]
[Next]
